Assignee
EVAXION BIOTECH AS
DK·3 granted patents·18 pending applications·0 citations·filing 2018–2024
Top patents by PatentIndex Score
21 records- 0184US2025205325A1Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniaeEVAXION BIOTECH AS·Filed 2024·Application pending·0 cites
- 0279US2024226263A1Peptides derived from acinetobacter baumannii and their use in vaccinationEVAXION BIOTECH AS·Filed 2023·Application pending·0 cites
- 0377US2024317817A1Proteins and nucleic acids useful in vaccines targeting Pseudomonas aeruginosaEVAXION BIOTECH AS·Filed 2024·Application pending·0 cites
- 0474US2024228554A9Proteins and nucleic acids useful in vaccines targeting staphylococcus aureusEVAXION BIOTECH AS·Filed 2023·Application pending·0 cites
- 0572US12006342B2Proteins and nucleic acids useful in vaccines targeting Pseudomonas aeruginosaEVAXION BIOTECH AS·Filed 2021·Granted Jun 11, 2024·0 cites·18 claims
- 0672US2021386847A1Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureusEVAXION BIOTECH AS·Filed 2021·Application pending·0 cites
- 0766US12209110B2Chimeric proteins for inducing immunity towards infection with S. aureusEVAXION BIOTECH AS·Filed 2022·Granted Jan 28, 2025·0 cites·24 claims
- 0861US2024424079A1Vaccines targeting Neisseria gonorrhoeaeEVAXION BIOTECH AS·Filed 2022·Application pending·0 cites
- 0957US2025095818A1Method for predicting response to cancer immunotherapyEVAXION BIOTECH AS·Filed 2022·Application pending·0 cites
- 1052US2025288657A1Staphylococcal protein variants and truncatesEVAXION BIOTECH AS·Filed 2022·Application pending·0 cites
- 1150US2023050225A1Vaccines targeting Neisseria gonorrhoeaeEVAXION BIOTECH AS·Filed 2021·Application pending·0 cites
- 1245US11718648B2Vaccines targeting Pseudomonas aeruginosaEVAXION BIOTECH AS·Filed 2018·Granted Aug 8, 2023·0 cites·9 claims
- 1345US2022143168A1Vaccines targeting H. influenzaeEVAXION BIOTECH AS·Filed 2020·Application pending·0 cites
- 1444US2025054576A1Personalized cancer therapy targeting normally non-expressed sequencesEVAXION BIOTECH AS·Filed 2022·Application pending·0 cites
- 1544US2023260594A1Process for preparation of neopepitope-containing vaccine agentsEVAXION BIOTECH AS·Filed 2021·Application pending·0 cites
- 1643US2025304626A1Vaccination targeting intracellular pathogensEVAXION BIOTECH AS·Filed 2021·Application pending·0 cites
- 1739US2023355733A1APC targeting units for immunotherapyEVAXION BIOTECH AS·Filed 2021·Application pending·0 cites
- 1837US2023147574A1Neoepitope immunotherapy with APC targeting unitEVAXION BIOTECH AS·Filed 2021·Application pending·0 cites
- 1936US2023072079A1Nucleic acid vaccination using neo-epitope encoding constructsEVAXION BIOTECH AS·Filed 2020·Application pending·0 cites
- 2033US2022334129A1Method for identifying T-cell epitopesEVAXION BIOTECH AS·Filed 2020·Application pending·0 cites
- 2133US2022184191A1Nucleic acid vaccination using neo-epitope encoding constructsEVAXION BIOTECH AS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EVAXION BIOTECH AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →